Cellular uptake of aminoglycosides, guanidinoglycosides, and poly-arginine

被引:141
作者
Luedtke, NW [1 ]
Carmichael, P [1 ]
Tor, Y [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
关键词
D O I
10.1021/ja0360135
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aminoglycosides (including neomycin B and tobramycin) exhibit poor uptake by eukaryotic cell lines. When the amines of these natural products are converted into guanidine groups, their cellular uptake is dramatically enhanced. We have synthesized BODIPY-containing aminoglycosides and guanidinoglycosides to evaluate their cellular uptake properties. Fluorescence activated cell sorting (FACS) and fluorescence microscopy are used to compare the membrane translocation and the cellular localization of these compounds. Upon guanidinylation, the cellular uptake efficiencies of tobramycin and neomycin B are enhanced by 10-fold and 20-fold, respectively. Guanidino-neomycin B exhibits a highly efficient uptake, superior to a fluorescent poly-arginine peptide. Interestingly, the cellular uptake of this common transduction peptide is inhibited by guanidine-neomycin B, suggesting a similar uptake mechanism for both the arginine-rich peptides and the guanidinoglycosides. Copyright © 2003 American Chemical Society.
引用
收藏
页码:12374 / 12375
页数:2
相关论文
共 18 条
[1]  
APPLE RJ, 1988, J IMMUNOL, V140, P3290
[2]   Synthesis and anti-HIV activity of guanidinoglycosides [J].
Baker, TJ ;
Luedtke, NW ;
Tor, Y ;
Goodman, M .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (26) :9054-9058
[3]   Aminoglycoside-derived cationic lipids as efficient vectors for gene transfection in vitro and in vivo [J].
Belmont, P ;
Aissaoui, A ;
Hauchecorne, M ;
Oudrhiri, N ;
Petit, L ;
Vigneron, JP ;
Lehn, JM ;
Lehn, P .
JOURNAL OF GENE MEDICINE, 2002, 4 (05) :517-526
[4]  
Bonetta L, 2002, SCIENTIST, V16, P38
[5]  
DAVIES J, 1968, J BIOL CHEM, V243, P3312
[6]   Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms [J].
Futaki, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 245 (1-2) :1-7
[7]  
Ho A, 2001, CANCER RES, V61, P474
[8]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25
[9]   Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: Synthesis and anti-HIV activities [J].
Litovchick, A ;
Lapidot, A ;
Eisenstein, M ;
Kalinkovich, A ;
Borkow, G .
BIOCHEMISTRY, 2001, 40 (51) :15612-15623
[10]   Guanidinoglycosides: A novel family of RNA ligands [J].
Luedtke, NW ;
Baker, TJ ;
Goodman, M ;
Tor, Y .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2000, 122 (48) :12035-12036